Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms

NCT03929497 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

96

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy based on the interim analysis in the 17972A study

Conditions

Schizophrenia

Interventions

DRUG: Lu AF11167

Sponsor

H. Lundbeck A/S